CNE000000F14
CNE000000F14
PLBIO
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 9.47B EUR | 8.35B EUR | 12.3B EUR | 13.01B EUR |
Enterprise Value | 9.46B EUR | 8.75B EUR | 12.65B EUR | 13.05B EUR |
Valuation Multiples | ||||
Trailing P/E | 35.57x | 57.07x | 53.06x | 43.68x |
Forward P/E | 9.32x | -- | -- | -- |
Price to Sales | 3.82x | 4.53x | 6.25x | 6.5x |
Price to Book | 1.16x | 1.04x | 1.52x | 1.61x |
EV/Revenue | 3.82x | 4.75x | 6.42x | 6.52x |
EV/EBITDA | 17.76x | 19.41x | 22.9x | 25.13x |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -3.95% | -4.27% | -4.63% | -4.41% |